ENO2 and lung cancer: The final model comprised 15 predictors, namely age, KPS, NSE, PLR, lymphocyte count, ALP, smoking history, intrathoracic metastasis, metastases to other sites, N_stage, M_stage, surgery for primary lung cancer foci, chemotherapy EGFR mutation, and TKI treatment.